VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Tuesday, December 30, 2025
Stock Comparison
Cadence Design Systems, Inc. vs Sanofi
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Cadence Design Systems, Inc.
CDNS · NASDAQ
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Cadence Design Systems, Inc.'s moat claims, evidence, and risks.
View CDNS analysisSanofi
SAN · Euronext Paris
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Cadence Design Systems, Inc. leads (84 / 100 vs 74 / 100 for Sanofi).
- Segment focus: Cadence Design Systems, Inc. has 3 segments (71% in Core EDA); Sanofi has 3 segments (79.8% in Pharma (Prescription Medicines)).
- Primary market structure: Oligopoly vs Oligopoly. Pricing power: Strong vs Moderate.
- Moat breadth: Cadence Design Systems, Inc. has 8 moat types across 3 domains; Sanofi has 5 across 3.
Primary market context
Cadence Design Systems, Inc.
Core EDA
Electronic design automation tools for semiconductor IC design and verification (digital, custom/analog, signoff, functional verification)
Global
Semiconductor designers (fabless and IDMs) and system companies with in-house silicon teams
Tool vendor / workflow platform
71%
Sanofi
Pharma (Prescription Medicines)
Branded prescription pharmaceuticals (immunology, rare disease, neurology, oncology, general medicines)
Global
Patients via payers/providers and channel partners (wholesalers, pharmacies, hospitals)
Research-based drug developer, manufacturer, and marketer
79.8%
Side-by-side metrics
Moat coverage
Shared moat types
Cadence Design Systems, Inc. strengths
Sanofi strengths
Segment mix
Cadence Design Systems, Inc. segments
Full profile >Core EDA
Oligopoly
Semiconductor IP
Oligopoly
System Design and Analysis
Competitive
Sanofi segments
Full profile >Pharma (Prescription Medicines)
Oligopoly
Vaccines
Oligopoly
Opella (Consumer Healthcare - Sanofi minority stake)
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.